| Termination of abnormal intrauterine pregnancies with intramuscular administration of dihomo 15 methyl prostaglandin F 2alpha. | |
| | |
MedLine Citation:
|
PMID: 990229 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A synthetic compound, 2a, 2b dihomo 15 (S) 15 methyl prostaglandin F 2 alpha methyl ester given 8-hourly by intramuscular injection was used to terminate pregnancies in 72 patients with a missed abortion, intrauterine fetal death, molar or anencephalic pregnancies. Treatment was successful in all cases. A 4 mg dose of loperamide given orally at 15 to 30 minutes before the injection of prostaglandin analogue prevented diarrhoea as a side effect. |
| | |
Authors:
|
S M Karim; S S Ratnam |
Related Documents
:
|
17896259 - Pregnancy termination using vaginal misoprostol in women with more than one caesarean s... 2744189 - Circulating levels of placental protein 14 and progesterone following mifepristone (ru3... 14692649 - Unilateral transverse arm defect with subterminal digital nubbins. 12920539 - Termination of pregnancy for fetal neurological abnormalities. 3370199 - Early pregnancy termination: a comparison between vacuum aspiration and medical abortio... 2694739 - Clinical trials with ru 486 (mifepristone): an update. 1957879 - Loxoscelism threatening pregnancy: five cases. 1533319 - Ectopic pregnancy. 21257349 - Help ldl-apheresis in two cases of familial hypercholesterolemic pregnant women. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British journal of obstetrics and gynaecology Volume: 83 ISSN: 0306-5456 ISO Abbreviation: Br J Obstet Gynaecol Publication Date: 1976 Nov |
Date Detail:
|
Created Date: 1977-01-29 Completed Date: 1977-01-29 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7503752 Medline TA: Br J Obstet Gynaecol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 885-9 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortion, Missed
/
drug therapy Abortion, Therapeutic* Anencephaly / drug therapy Diarrhea / chemically induced, drug therapy Female Fetal Death / drug therapy Humans Hydatidiform Mole / drug therapy Loperamide / therapeutic use Pregnancy Pregnancy Complications / drug therapy* Prostaglandins F / therapeutic use Prostaglandins, Synthetic / administration & dosage, adverse effects, therapeutic use* Uterine Neoplasms / drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Prostaglandins F; 0/Prostaglandins, Synthetic; 53179-11-6/Loperamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Placental transfer and fetal uptake of 3H-digoxin in humans.
Next Document: Carcinoma of the cervical stump.